search
Back to results

Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity (H42/H4U)

Primary Purpose

Pregnancy Weight Gain, Postpartum Weight Retention, Childhood Obesity

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Healthy for Two/Healthy for You
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Pregnancy Weight Gain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Age≥18
  • Singleton pregnancy
  • ≤15 weeks gestation with documented prenatal weight and height in electronic health record
  • Body mass index ≥ 25.0 kg/m2
  • English-speaking
  • Has smartphone, laptop or tablet and willing to use it for this study
  • Has email address and willing to use for this study

Exclusion Criteria:

  • BMI <25 kg/m2
  • Multiple fetuses
  • History of pre-gestational Type 1 or Type 2 diabetes or taking diabetes medication for treatment of diabetes prior to first prenatal visit
  • Prior history of severe preeclampsia, pre-term birth (< 32 weeks gestation)
  • Poorly controlled blood pressure (> 160/100 mmHg)
  • Substance use disorder or positive urine toxicology (except for THC) for illicit substances (screening done as part of routine care)
  • Psychiatric hospitalization in last 12 months or diagnosis of severe mental illness that is not well controlled
  • Active diagnosis of an eating disorder
  • Unable to walk 1 block without pain or shortness of breath
  • No email address
  • Unable to speak or read in English
  • Planning to move in next 12 months

Sites / Locations

  • Johns Hopkins Health System and UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Healthy for Two/Healthy for You (H42/H4U)

Usual Care Comparison Group: Maintain Health in Pregnancy (mHIP)

Arm Description

Those assigned to the intervention group will receive the H42/H4U health coaching intervention during pregnancy and 12 weeks postpartum.

Those assigned to the Usual Care comparison group, mHIP, will receive typical, evidence- and guideline-based experience in the prenatal care clinics.

Outcomes

Primary Outcome Measures

Total gestational weight gain
Difference between weight (lbs) at 37 weeks and baseline first trimester weight, measured prior to 15 weeks gestation.

Secondary Outcome Measures

Number of participants who gained excess weight
Number of participants who gained above the Institute of Medicine recommended weight gain goal.
Incidence of gestational diabetes mellitus
Defined and validated by electronic health record diagnosis.
Postpartum weight retention
Difference between baseline (≤ 15 weeks gestation weight) and 6 month post delivery maternal weight (lbs).
Infant weight
Weight (lbs) of infant assessed by electronic health record.
Proportion of low birth weight infants
Proportion of infants weighing < 2500 grams at birth.

Full Information

First Posted
January 22, 2021
Last Updated
March 28, 2023
Sponsor
Johns Hopkins University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT04724330
Brief Title
Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity
Acronym
H42/H4U
Official Title
Healthy for 2/Healthy for U: A Pragmatic Randomized Clinical Trial to Limit Gestational Weight Gain and Prevent Obesity in Johns Hopkins Prenatal Care Practices
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 15, 2021 (Actual)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Healthy for Two, Healthy for You (H42/H4U) is an innovative evidence-based pregnancy/postpartum health coach intervention that is remotely-delivered (phone coaching using motivational interviewing, web-based platform, mobile phone behavioral tracking). The aim of this randomized controlled trial (RCT) is to embed H42/H4U into Johns Hopkins prenatal care clinics that serve a racially and economically diverse population, leveraging existing staff as trained health coaches to test its effectiveness and implementation. The investigators hypothesize that women in the H42/H4U arm will have lower gestational weight gain and lower rates of gestational diabetes, without an increase in low birth weight infants, and that implementation into the investigators' prenatal care clinics will be feasible and scalable.
Detailed Description
Despite two decades of public health efforts to combat obesity, rates continue to rise and racial disparities persist. There is an urgent need to re-focus obesity prevention efforts onto young adults, particularly reproductive age women. 23% of women (vs. 13% of men) gain ≥20 kg from age 18 to 55 years, with the highest weight gain in African American women who gain > 1kg/year. Importantly, weight gain of ≥20 kg is associated with development of type 2 diabetes (DM), other obesity-related comorbidities and greater mortality. For women who become pregnant, pregnancy provides an important opportunity for obesity and DM prevention, as excessive gestational weight gain (GWG) and pregnancy complications [e.g. gestational diabetes (GDM)], increase future DM risk. Promoting healthy GWG through behavioral interventions may prevent these pregnancy complications, but importantly has great potential for long-term, sustainable benefits to prevent postpartum weight retention (PPWR) and future obesity and DM, in women and the women's children. With the publication of the LIFE-Moms consortium's results, there is now strong evidence from efficacy trials showing that limiting GWG is achievable and associated with improved exercise and dietary behaviors. Several notable research gaps and next steps have emerged from the LIFE-Moms' studies, which the investigators address in this pragmatic trial. Because these studies were designed to test the efficacy of behavioral weight management on GWG, interventions were resource intensive (i.e. in-person counseling and with limited online and mobile technologies), without a focus on program implementation and sustainability in routine prenatal care settings and lacking intervention in the vulnerable postpartum period. To address these critical evidence gaps and reduce obesity associated with the pregnancy/postpartum periods, the next step is to integrate and test an evidence-based lifestyle intervention in pregnancy and postpartum that utilizes remote delivery of counseling, enables self-monitoring by patients using mobile and online technologies and supports obstetric providers and clinics to optimize care for women at high risk for obesity and future DM. The investigators' experienced team created and tested Healthy for Two / Healthy for You (H42/H4U). H42/H4U is an innovative evidence-based pregnancy/postpartum health coaching intervention that is remotely-delivered (phone coaching using motivational interviewing + web-based platform + mobile phone behavioral tracking). The aim of this R18 pragmatic randomized controlled trial (RCT) is to embed H42/H4U into prenatal care clinics that serve a racially and economically diverse population, leveraging existing staff as trained health coaches and community health workers (CHWs), to test its effectiveness and implementation. The investigators hypothesize that women in the H42/H4U arm will have lower GWG and lower rates of GDM, without an increase in low birth weight infants, and that implementation into the investigators' prenatal care clinics will be feasible and scalable. The investigators will rigorously test this hypothesis through the following Specific Aims: Aim 1. Test the effectiveness of H42/H4U integrated into prenatal care compared with Usual Care among 380 pregnant and postpartum women enrolled from 6 prenatal clinics on: A. Primary outcome: GWG (37 week minus baseline pregnancy [≤15 week gestation] weight) B. Maternal secondary outcomes: Proportion with excessive GWG; GDM incidence; PPWR at 6 months after delivery C. Infant secondary outcomes: Weight at birth, 4 and 6 months. D. Other outcomes: Maternal health behaviors (diet, physical activity, breastfeeding); Maternal wellness (depression, sleep and stress) Aim 2. Assess organizational factors that impact the implementation of the intervention into prenatal care clinics, including costs of intervention delivery and provider and staff satisfaction to inform future dissemination. A. Provider and staff perspectives, including satisfaction, workflow barriers and potential for sustainability, using qualitative semi-structured interviews (n=15 at baseline and end of study). B. Cost analysis to assess intervention delivery costs and the return on investment (ROI) of H42/H4U. This study will advance a potentially powerful, prenatal care-based strategy to reduce obesity in young adult childbearing women and thereby the intergenerational effects on the women's children. The investigators' interdisciplinary team brings together engaged academic and community-based obstetricians, the investigators' health system's population health program and researchers with experience in developing, testing and implementing behavioral interventions in both pregnant and non-pregnant adults in real world settings to enable wide dissemination. Ultimately, the investigators' goal is to design and produce an effective and scalable behavioral strategy, integrated into clinical practice that will: 1) reduce excessive GWG and its associated pregnancy complications, 2) reduce future obesity, DM and other obesity-related complications in mothers and the mothers' children, and 3) ensure high quality care delivery that prevents obesity and DM through a population health approach to prenatal care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pregnancy Weight Gain, Postpartum Weight Retention, Childhood Obesity, Gestational Diabetes, Overweight and Obesity

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
380 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Healthy for Two/Healthy for You (H42/H4U)
Arm Type
Experimental
Arm Description
Those assigned to the intervention group will receive the H42/H4U health coaching intervention during pregnancy and 12 weeks postpartum.
Arm Title
Usual Care Comparison Group: Maintain Health in Pregnancy (mHIP)
Arm Type
No Intervention
Arm Description
Those assigned to the Usual Care comparison group, mHIP, will receive typical, evidence- and guideline-based experience in the prenatal care clinics.
Intervention Type
Behavioral
Intervention Name(s)
Healthy for Two/Healthy for You
Other Intervention Name(s)
H42/H4U
Intervention Description
~10 month (early pregnancy to 12 weeks postpartum), remotely-delivered, behavioral lifestyle intervention including health coach contacts (via phone, videoconference, and email/MyChart) and an interactive web-based platform.
Primary Outcome Measure Information:
Title
Total gestational weight gain
Description
Difference between weight (lbs) at 37 weeks and baseline first trimester weight, measured prior to 15 weeks gestation.
Time Frame
At 37 weeks in pregnancy
Secondary Outcome Measure Information:
Title
Number of participants who gained excess weight
Description
Number of participants who gained above the Institute of Medicine recommended weight gain goal.
Time Frame
At 37 weeks in pregnancy
Title
Incidence of gestational diabetes mellitus
Description
Defined and validated by electronic health record diagnosis.
Time Frame
At 37 weeks in pregnancy
Title
Postpartum weight retention
Description
Difference between baseline (≤ 15 weeks gestation weight) and 6 month post delivery maternal weight (lbs).
Time Frame
6 months after delivery
Title
Infant weight
Description
Weight (lbs) of infant assessed by electronic health record.
Time Frame
At 6 months of age
Title
Proportion of low birth weight infants
Description
Proportion of infants weighing < 2500 grams at birth.
Time Frame
At time of birth/delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age≥18 Singleton pregnancy ≤15 weeks gestation with documented prenatal weight and height in electronic health record Body mass index ≥ 25.0 kg/m2 English-speaking Has smartphone, laptop or tablet and willing to use it for this study Has email address and willing to use for this study Exclusion Criteria: BMI <25 kg/m2 Multiple fetuses History of pre-gestational Type 1 or Type 2 diabetes or taking diabetes medication for treatment of diabetes prior to first prenatal visit Prior history of severe preeclampsia, pre-term birth (< 32 weeks gestation) Poorly controlled blood pressure (> 160/100 mmHg) Substance use disorder or positive urine toxicology (except for THC) for illicit substances (screening done as part of routine care) Psychiatric hospitalization in last 12 months or diagnosis of severe mental illness that is not well controlled Active diagnosis of an eating disorder Unable to walk 1 block without pain or shortness of breath No email address Unable to speak or read in English Planning to move in next 12 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wendy L Bennett, MD, MPH
Phone
4105026081
Email
wendy.bennett@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
NaeYuh Wang, PhD
Phone
4106143994
Email
naeyuh@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wendy L Bennett, MD, MPH
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Health System and University
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wendy L Bennett
Phone
410-502-6081
Email
wendy.bennett@jhmi.edu
First Name & Middle Initial & Last Name & Degree
Stephen Martin, MD
Email
smarti99@jhmi.edu

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34896296
Citation
Bennett WL, Coughlin JW, Henderson J, Martin S, Yazdy GM, Drabo EF, Showell NN, McKinney C, Martin L, Dalcin A, Sanders R, Wang NY. Healthy for Two/Healthy for You: Design and methods for a pragmatic randomized clinical trial to limit gestational weight gain and prevent obesity in the prenatal care setting. Contemp Clin Trials. 2022 Feb;113:106647. doi: 10.1016/j.cct.2021.106647. Epub 2021 Dec 8.
Results Reference
background

Learn more about this trial

Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity

We'll reach out to this number within 24 hrs